The committee’s role is to define & evaluate the practices of managed care pharmacy and to develop guidelines specific to those practices consistent with the AMCP mission.
The committee’s role is to ensure AMCP’s awareness of issues that impact student pharmacists as well as provide oversight to the AMCP Student Chapter program.
The committee’s role is to develop and maintain AMCP’s bylaws, organizational policies, procedures, and structure consistent with the AMCP mission.
The Educational Affairs Committee role is to ensure that AMCP education programs are highly relevant and valuable to members.
May 2019 News & Views: Survey Identifies Barriers and Solutions to Biosimilar Adoption; In Memoriam: Past President Cathy Carroll; CEO Blog: PAs Play Key Role in Appropriate Medication Use; PGY1 Residents First to Rotate at AMCP/Foundation Headquarters
From April 2019 News & Views: Four student pharmacists from the University of Washington School of Pharmacy took top honors in the Academy of Managed Care Pharmacy (AMCP) Foundation 19th National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition.
From April 2019 News & Views: Nearly 4,200 Attendees Gather for AMCP Annual Meeting; Revitalized AMCP Brand Reflects Forward-Thinking Approach; CEO Susan A. Cantrell Blog; AMPC President James Kenney Addresses General Session
From April 2019 News & Views: AMCP and the AMCP Foundation last month recognized a group of thought leaders for their significant contributions to the profession of managed care pharmacy.
From April 2019 News & Views: Managing access to gene therapy, mitigating risk of inappropriate opioid utilization, the current state of value-based contracting, and drug pricing reform efforts are just some topics of the nearly 40 educational sessions that took place at the AMCP Managed Care & Specialty Pharmacy Annual Meeting last week in San Diego.
From April 2019 News & Views: AMCP: Optimizing Medicine. Improving Lives. That’s the message of AMCP’s revitalized brand and logo, which were unveiled last week at the General Session of the Annual Meeting 2019 in San Diego, California.
From April 2019 News & Views: James Kenney took the helm as 2019-2020 AMCP President at the Annual Meeting last week in San Diego. The following is a lightly edited version of his inaugural address at the General Session.
From April 2019 News & Views: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies. But formidable barriers, including concerns about safety and efficacy among prescribers and state laws on substitution and interchangeability, have hindered biosimilar adoption.
